Updated Jul 16, 2026
Campbell Bradley L has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $2.87M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-27 | FOLD | AMICUS THERAPEUTICS, INC. | D — Derivative transaction | 1.01M | $14.50 | $14.63M |
| 2026-03-05 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 22.5K | $14.35 | $323K |
| 2026-01-23 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 75.0K | $14.31 | $1.07M |
| 2026-01-23 | FOLD | AMICUS THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 75.0K | $6.10 | $458K |
| 2025-12-30 | FOLD | AMICUS THERAPEUTICS, INC. | F — Tax withholding / forfeiture | 108.6K | $14.25 | $1.55M |
| 2025-12-17 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 77.9K | $10.86 | $846K |
| 2025-12-17 | FOLD | AMICUS THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 70.4K | $9.03 | $636K |
| 2025-12-04 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 14.6K | $10.01 | $146K |
| 2025-12-04 | FOLD | AMICUS THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 14.6K | $9.03 | $132K |
| 2025-11-27 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 14.6K | $10.04 | $147K |
| 2025-11-27 | FOLD | AMICUS THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 14.6K | $9.03 | $132K |
| 2024-12-03 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 7.5K | $10.02 | $75K |
| 2024-12-03 | FOLD | AMICUS THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 7.5K | $8.61 | $65K |
| 2024-11-07 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 7.9K | $12.50 | $99K |
| 2024-11-07 | FOLD | AMICUS THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 7.9K | $12.28 | $97K |
| 2024-11-04 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 7.5K | $11.46 | $86K |
| 2024-11-04 | FOLD | AMICUS THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 7.5K | $8.61 | $65K |
| 2024-10-04 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 7.5K | $10.60 | $79K |
| 2024-10-04 | FOLD | AMICUS THERAPEUTICS, INC. | M — Option exercise [10b5-1] | 7.5K | $8.61 | $65K |
Campbell Bradley L is a corporate insider — currently tracked as Insider of AMICUS THERAPEUTICS, INC. (FOLD). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 9 open-market sales ($2.87M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Campbell Bradley L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.